期刊文献+

囊泡单胺转运体在脑组织中的分布特征与帕金森病相关性的研究 被引量:1

A study of relationships between distribution of vesicular monoamine transporter in brain and PD
下载PDF
导出
摘要 目的探讨囊泡单胺转运体(VMAT2)在脑组织中的分布特征与帕金森病(PD)的关系。方法使用利血平、神经毒素1-甲基-4-苯基-四氢吡啶(MPTP)及联合利血平和MPTP分别造成C57BL小鼠的PD模型和分别收集不同胎龄自然流产的新鲜胎儿,应用免疫组织化学方法和Western blot观察VMAT2和酪胺酸羟化酶(TH)在黑质致密部、腹侧被盖和蓝斑分布的变化。结果免疫组织化学分析及Western blot显示,PD小鼠较对照组小鼠VMAT2和TH阳性神经元细胞数目在黑质致密部明显减少,腹侧被盖和蓝斑中的阳性神经元细胞数无明显变化;同时发现在小鼠正常对照组和人胎脑中VMAT2在黑质致密部中的分布既少于腹侧被盖也少于蓝斑。结论这种对多巴胺神经元具有保护作用的VMAT2在黑质致密部中的分布少于腹侧被盖和蓝斑,黑质致密部保护作用薄弱是PD黑质选择性受损的重要原因。 Objective To investigate the distribution of vesicular monoamine transporter(VMAT2) in brain and their relationships with Parkinson disease(PD). Methods PD model of C57BL mice induced by reserpine, MPTP, reserpine plus MPTP was used respectively and human embryonic brains of different parts (substantia nigrapars compacta,SNC), ventral tegmental areas(VTA) and locus coeruleus (LC) were examined by immunohistochemistrical staining and Western blot. Results The number of VMAT2- positive neurons and the number of TH- positive neurons in SNC were significantly reduced in PD model than the control, but there was no great difference in VTA and LC between PD model and the control. The distribution of VMAT2 in the control and human embryonic brains in SNC was less than that in both VTA and LC. Conclusion The amount of VMAT2 that has protective effect on the DA neurons in SNC is less than that in both VTA and LC. The weakage of the protecting function of VMAT2 in SNC may be the important cause of the selective DA neurons loss.
出处 《山西医药杂志(上半月)》 CAS 2009年第10期896-898,共3页 Shanxi Medical Journal
关键词 帕金森病 免疫组织化学 囊泡单胺转运体 酪胺酸羟化酶 Parkinson diseasel Immunohistochemistry Vesicular monoamine transporter Tyrosine hydroxylase
  • 相关文献

参考文献6

  • 1Buck K J, Amara SG. Chimeric dopamine- norepinephrine transporters delineote structural domains influencing selectivity for catecholamine and 1-methyl-4-phenylpyridinium. Proc Natl Acad Sci USA, 1994, 91 : 12584-12588.
  • 2Liu Y, Peter D, Roghani A, et al. A cDNA that suppresses MPP^+ toxicity encodes a vesicular amine transporter. Cell, 1992,70(4) : 539-551.
  • 3Kosel S, Hofhaus G, Maassen A. Role of mitochondria in Parkinson disease. Biol Chem, 1999,380(7-8):865-870.
  • 4Miller GW, Erickson JD, Perez JT, et al. Immunochemical analysis of vesicular monoamine transporter protein in Parkinson's disease. Exp Neurol, 1999,156: 138-148.
  • 5German DC, Liang CL, Manaye KF, et al. Pharmacological inactivation of the vesicular monoamine transporter can enhance MPTP-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrnergic neurons. Neuroscience, 2000,101 : 1063-1069.
  • 6田向阳,丁新生,闵敏,孙兴珍.囊泡单胺转运体在人胚胎脑组织中的分布特征及其与帕金森病的关系[J].临床神经病学杂志,2008,21(4):270-272. 被引量:2

二级参考文献7

  • 1[2]Peter D,Jimenez J,Liu Y,et al.The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors[J].J Biol Chem,1994,269:7231.
  • 2[3]Speciale SG.MPTP insights into parkinsonian neurodegeneration[J].Neurotoxicol Teratol,2002,24:607.
  • 3[4]Liu YJ,Peter D,Roghani A,et al.A cDNA that suppresses MPP+ toxicity encodes a vesicular monoamine transporter[J].Cell,1992,70:539.
  • 4[5]Fumagalli F,Gainetdinov RR,Wang YM,et al.Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knockout mice[J].J Neurosci,1999,19:2424.
  • 5[6]Miller GW,Erickson JD,Perez JD,et al.Immunochemical analysis of vesicular monoamine transporter protein in Parkinson′s disease[J].Experimental Neurology,1999,156:138.
  • 6叶民,丁新生,董海蓉,仇镇宁,管晓虹.转基因CHO细胞中VMAT_2抗毒性作用的研究[J].临床神经病学杂志,2002,15(2):69-72. 被引量:7
  • 7田向阳,丁新生,董海蓉.囊泡单胺转运体在帕金森病小鼠脑组织中的分布特征[J].南京医科大学学报(自然科学版),2004,24(3):246-249. 被引量:4

共引文献1

同被引文献2

  • 1Olanow CW,Watts RL,Koller WC. An algorithm (decision tree) for the management of Parkinson,disease (2001):treatment guidelines.Neurology, 2001,56 ( 11 ): 1.
  • 2王慧媛,杜彦,赵志刚.帕金森病的药物治疗研究进展[J].中国药房,2007,18(32):2543-2545. 被引量:8

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部